J Korean Med Assoc Search


J Korean Med Assoc > Volume 56(5); 2013 > Article
Journal of the Korean Medical Association 2013;56(5):402-409.
Published online May 20, 2013.
DOI: https://doi.org/10.5124/jkma.2013.56.5.402   
Recent advances in thrombolysis of acute ischemic stroke
Jee Hyun Kwon, Joung Ho Rha
1Department of Neurology, Ulsan University Hospital, Ulsan University College of Medicine, Ulsan, Korea.
2Department of Neurology, Inha University College of Medicine, Incheon, Korea. jhrha@inha.ac.kr
Among the many advances in acute ischemic stroke (AIS) management, thrombolysis with intravenous (IV) tissue plasminogen activator (tPA) within 3 hours after symptom onset has been the only approved pharmacological therapy in AIS. However, IV administration of tPA has many limitations in clinical practice, and the proportion of eligible patients remains quite low. Many clinical trials have attempted to overcome this by increasing the therapeutic time window and enhancing the efficacy of reperfusion by the intra-arterial (IA) approach with novel mechanical devices. In addition, the application of new thrombolytic agents and identification of suitable thrombolytic candidates by multimodal brain imaging is another field of active research in thrombolytic therapy. We reviewed AIS management, focusing on thrombolysis with IV therapy, IA therapy, and IV-IA bridging therapy.
Key Words: Acute ischemic stroke, Tissue plasminogen activator, Thrombolysis, Intravenous thrombolysis, Intra-arterial thrombolysis


Browse all articles >

Editorial Office
Samgu B/D 7F, 40 Cheongpa-ro, Youngsan-gu, Seoul 04373, Korea
Tel: +82-1566-2844    Fax: +82-2-792-5208    E-mail: jkmamaster@gmail.com                

Copyright © 2022 by Korean Medical Association.

Developed in M2PI

Close layer
prev next